Our group’s previous research found that ATB was associated with a poor clinical outcome in glioma patients, and its depletion attenuated glioma biological characteristics by directly repression miR-200a, and positively regulating TGF-β2 expression in glioma cells [40]. This evidence concerns the gene TGFB2 and central nervous system cancer.